文献速递免疫规划

灭活与活二价禽腺病毒(FAdV8b + FAdV11)种鸡疫苗为雏鸡提供针对包涵体肝炎的广谱保护

Inactivated and live bivalent fowl adenovirus (FAdV8b + FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
PubMed 文献 · Vaccine · 2017-12-29

本研究评估二价(D和E种)活疫苗与灭活FAdV种鸡疫苗通过母源抗体转移保护肉鸡雏鸡抵抗包涵体肝炎的效果。FAdV血清阴性种鸡每组300只分别接受活疫苗或灭活疫苗,对照组150只口服生理盐水。雏鸡对同源或异源FAdV攻击显示98-100%保护,表明两种疫苗效果相当并具有控制包涵体肝炎的潜力。

要点

  • 活疫苗与灭活疫苗组在19、30和48周龄的平均中和抗体相似,范围为2.4至3.7 log10。
  • 约26 ± 7%的母源抗体通过蛋被动转移至一日龄雏鸡。
  • 雏鸡在14日龄受致死剂量FAdV攻击时,同源或异源攻击均显示98-100%保护。

核心结论

  • 数据表明二价活疫苗与灭活FAdV疫苗效果相当,并具有控制包涵体肝炎的潜力。

研究设计与样本

  • 研究评估二价(D和E种)活疫苗与灭活FAdV种鸡疫苗通过母源抗体转移保护肉鸡雏鸡抵抗包涵体肝炎的效果。
  • FAdV血清阴性种鸡每组300只,分别接受活疫苗或灭活二价(FAdV-8b-SK + FAdV-11-1047)疫苗;对照组150只口服生理盐水。
  • 活疫苗(每种病毒1 × 104 TCID50/只)在16周龄口服一次;灭活疫苗(每种病毒1 × 106 TCID50 + 20% Emulsigen D)在16和19周龄肌肉注射。
  • 灭活疫苗组在3周后用相同疫苗加强免疫;在19、22、30和48周龄检测血清(n = 10)中的中和抗体。

主要发现

  • 血清中和抗体能够中和D和E种内的多种FAdV血清型。
  • 活疫苗组与灭活疫苗组在19、30和48周龄的平均中和抗体相似,范围为2.4至3.7 log10。
  • 约26 ± 7%的母源抗体通过蛋被动转移至一日龄雏鸡。
  • 雏鸡在14日龄受致死剂量(1 × 107 TCID50/只肌肉注射)FAdV-8b-SK、FAdV-11-1047或FAdV-2-685攻击(每组n = 90)时,对同源或异源FAdV攻击显示98-100%保护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fowl adenovirus (FAdV) is comprised of five species (A to E) and 12 serotypes (1-7, 8a, 8b, 9-11). Inclusion body hepatitis (IBH) is caused by FAdV-7, 8a, 8b (species E) and FAdV-2 and 11 (species D). Commercial vaccines against IBH are not available in Canada. Autogenous FAdV broiler breeder vaccines are now used in some areas where outbreaks of IBH are occurring. The objective of this study was to evaluate the efficacy of a bivalent (species D and E) live and an inactivated FAdV broiler breeder vaccine in protecting broiler chicks against IBH through maternal antibody (MtAb) transfer. FAdV seronegative broiler breeders (n = 300/group) received either a live or inactivated bivalent (FAdV-8b-SK + FAdV-11-1047) vaccine. The live vaccine (1 × 104 TCID50 of each virus/bird) was given orally once at 16 weeks of age and the inactivated vaccine (1 × 106TCID50 of each virus + 20% Emulsigen D) was given intramuscularly at 16 and 19 weeks of age. Controls (n = 150) were given saline orally. The inactivated vaccine group was boosted 3 weeks later with the same vaccine. Neutralizing antibodies (NAb) in sera (n = 10) were detected at 19, 22, 30 and 48 weeks of age. NAb were able to neutralize various FAdV serotypes within species D and E. Mean NAb were similar in the both live and killed vaccine groups at 19, 30 and 48 weeks and ranged from 2.4 to 3.7 log10. Approximately 26 ± 7% of MtAbs were passively transferred through eggs to day-old chicks. Progeny challenged with a lethal dose (1 × 107 TCID50/bird intramuscularly) of FAdV-8b-SK, FAdV-11-1047, or FAdV-2-685 (n = 90/group) at 14 days post-hatch (dph) showed 98-100% protection in broiler chicks to homologous or heterologous FAdV challenges. Our data suggests that a bivalent live and an inactivated FAdV vaccine are equally effective and have the potential for the control of IBH.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gupta A, Popowich S, Ojkic D, et al. Inactivated and live bivalent fowl adenovirus (FAdV8b + FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH). Vaccine. 2017. PMID: 29292175. doi:10.1016/j.vaccine.2017.12.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。